Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2024Open Access

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster Model

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSwayam PrakashNDNisha R. DhanushkodiMSMahmoud Singer

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Prakash et al. (2024) studied this question.

synapsesocial.com/papers/68e78f6db6db643587701418https://doi.org/10.1101/2024.02.14.580225
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models2022 · 131 citations
  2. 2Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity2020 · 1,989 citations
  3. 3Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters2022 · 23 citations
  4. 4Vaccines against SARS-CoV-2 variants and future pandemics2022 · 25 citations
  5. 5Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting2023 · 60 citations